Literature DB >> 19062486

Reconstruction after pancreaticoduodenectomy: isolated Roux loop pancreatic anastomosis.

Riccardo Casadei1, Nicola Zanini, Raffaele Pezzilli, Lucia Calculli, Claudio Ricci, Nicola Antonacci, Francesco Minni.   

Abstract

Pancreatic fistula is the most frequent major complication after pancreaticoduodenectomy. Its rate may be related to several risk factors, among which pancreatic anastomotic reconstruction techniques. The study reported here was a prospective, non-randomized study of 38 consecutive patients who underwent pancreaticoduodenectomy from March 2006 to February 2007. Two groups were studied according to the type of treatment of the pancreatic remnant: group 1 (n = 18) in which an isolated Roux loop Wirsung-jejunal end-to-side anastomosis was performed; and group 2 (n = 20) in which a pancreaticojejunostomy was carried out in the same jejunal loop as the biliary and gastric anastomosis. The two groups of patients were compared regarding preoperative characteristics, surgical procedure and postoperative outcome. Postoperative mortality, morbidity and pancreatic fistula in all the patients in the two groups were evaluated in relation to several risk factors. The overall postoperative mortality and morbidity rates were 2.6% (1/38 cases) and 26.3% (10/38 cases), respectively. The pancreatic fistula rate was 13.1% (5 cases). There were no significant differences in postoperative outcome between the two groups. However, both mean and median postoperative postoperative hospital stay were shorter in group 1 than in group 2 (P < 0.001). Postoperative pancreatic fistula was not significantly more frequent in relation to any of the different risk factors. The isolated Roux loop Wirsung-jejunal end-to-side anastomosis after PD is safe, easy to perform and allows the same results of pancreaticojejunostomy in the same jejunal loop of the biliary and gastric anastomosis. Moreover the isolated Roux loop reconstruction allows a significant decrease of the length of postoperative hospital stay.

Entities:  

Mesh:

Year:  2008        PMID: 19062486

Source DB:  PubMed          Journal:  Chir Ital        ISSN: 0009-4773


  6 in total

1.  Single versus double Roux-en-Y reconstruction techniques in pancreaticoduodenectomy: a comparative single-center study.

Authors:  Faik G Uzunoglu; Matthias Reeh; Romy Wollstein; Nathaniel Melling; Daniel Perez; Yogesh K Vashist; Dean Bogoevski; Jakob R Izbicki; Maximilian Bockhorn
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

2.  Isolated Roux loop pancreaticojejunostomy versus pancreaticogastrostomy after pancreaticoduodenectomy: a prospective randomized study.

Authors:  Ayman El Nakeeb; Emad Hamdy; Ahmad M Sultan; Tarek Salah; Waleed Askr; Helmy Ezzat; Mohamed Said; Mostaffa Abu Zeied; Tallat Abdallah
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

3.  Isolated Roux loop pancreaticojejunostomy versus conventional pancreaticojejunostomy after pancreaticoduodenectomy: A case-control study.

Authors:  Amine Chhaidar; Mohamed Ben Mabrouk; Ali Ben Ali
Journal:  Int J Surg Case Rep       Date:  2018-10-31

Review 4.  Roux-en-Y and Billroth II Reconstruction after Pancreaticoduodenectomy: A Meta-Analysis of Complications.

Authors:  Fulin Ma; Yong Fan; Lina Zhang; Zhiqiang Zhao; Yuanhua Nie; Minxue Chen; Chen Wang
Journal:  Biomed Res Int       Date:  2020-12-03       Impact factor: 3.411

5.  Pancreatico-Jejunostomy On Isolated Loop After Pancreatico-Duodenectomy: Is It Worthwhile?

Authors:  Gennaro Clemente; Agostino Maria De Rose; Elena Panettieri; Francesco Ardito; Marino Murazio; Gennaro Nuzzo; Felice Giuliante
Journal:  J Gastrointest Surg       Date:  2022-03-16       Impact factor: 3.267

6.  Comparison of surgical outcomes between isolated pancreaticojejunostomy, isolated gastrojejunostomy, and conventional pancreaticojejunostomy after pancreaticoduodenectomy: a systematic review and meta-analysis.

Authors:  Yunxiao Lyu; Bin Wang; Yunxiao Cheng; Yueming Xu; Wei Bing Du
Journal:  BMC Gastroenterol       Date:  2020-08-20       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.